Natural Products for Chemopreventive and Adjunctive Therapy in Oncologic Disease

REFERENCES

• Cassileth , B R and Deng , G . 2004 . Complementary and alternative therapies for cancer . Oncologist , 9 : 80 – 89 .
   PubMed Web of Science ®Google Scholar
• Hyodo , H , Eguchi , K , Nishina , T , Endo , H Tanimizu , M . 2003 . Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan . Cancer , 97 : 2861 – 2868 .
   PubMed Web of Science ®Google Scholar
• National Center for Nutritional Supplements . May 2007 . The use of nutritional supplements in the United States May , Bethesda, MD Available at http://ncNutritionalsupplements.nih.gov/news/Nutritionalsupplementssurvey_fs1.htm[cited 2007 June]
   Google Scholar
• Dy , G K , Bekele , L , Hanson , L J , Furth , A Mandrekar , S . 2004 . Nutritional supplements use by patients enrolled onto phase I clinical trials . J Clin Oncol , 22 : 4810 – 4815 .
   PubMed Web of Science ®Google Scholar
• Ernst , E and Cassileth , B R . 1998 . The prevalence of complementary/alternative medicine in cancer: a systematic review . Cancer , 83 : 777 – 782 .
   PubMed Web of Science ®Google Scholar
• Tascilar , M , De Jong , F A , Verweij , J and Matheijssen , R HJ . 2006 . Nutritional supplements during cancer treatment: beyond innocence . Oncologist , 11 : 732 – 741 .
   PubMed Web of Science ®Google Scholar
• Molassiotis , A , Fernandez-Ortega , P Pud , D . 2005 . Use of nutritional supplements in cancer patients: a European survey . Ann Oncol , 16 : 655 – 663 .
   PubMed Web of Science ®Google Scholar
• Cui , Y , Shu , X O , Gao , Y , Wen , W Ruan , Z X . 2004 . Use of nutritional supplements by Chinese women with breast cancer . Breast Cancer Res Treat , 85 : 263 – 270 .
   PubMed Web of Science ®Google Scholar
• Patterson , R E , Neuhouser , M L , Hedderson , M M , Schwartz , S M Standish , L J . 2002 . Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs . J Altern Complement Med , 8 : 477 – 485 .
   PubMed Web of Science ®Google Scholar
• Eisenberg , D M , Davis , R B , Ettner , S L , Appel , S Wilkey , S . 1998 . Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey . JAMA , 280 : 1569 – 575 .
   PubMed Web of Science ®Google Scholar
• NCNutritional Supplements [Internet] . Available at http://ncNutritionalsupplements.nih.gov/research/strategy/2006.htm Bethesda (MD): Funding Strategy: Fiscal Year 2006. 2006 [cited 2007 June 20]
   Google Scholar
• De Smet , P A . 2005 . Herbal medicine in Europe—relaxing regulatory standards . N Engl J Med , 352 : 1176 – 1178 .
   PubMed Web of Science ®Google Scholar
• Ashbury , F D , Findlay , H , Reynolds , B and McKerracher , K . 1998 . A Canadian survey of cancer patients' experiences: are their needs being met? . J Pain Symptom Manage , 16 : 298 – 306 .
   PubMed Web of Science ®Google Scholar
• Cauffield , J S . 2000 . The psychosocial aspects of complementary and alternative therapies for cancer . Pharmacotherapy , 20 : 1289 – 1294 .
   PubMed Web of Science ®Google Scholar
• Jian , L , Xie , L P , Lee , A H and Binns , C W . 2004 . Protective effect of green tea against prostate cancer: case control study in South East China . Int J Cancer , 108 : 130 – 135 .
   PubMed Web of Science ®Google Scholar
• Straus , S E . 2002 . Herbal medicines—what's in the bottle? . N Engl J Med , 347 : 1997 – 1998 .
   PubMed Web of Science ®Google Scholar
• Cassileth , B R , Lusk , E J , Strouse , T B and Bodenheimer , B J . 1984 . Contemporary unorthodox treatments in cancer medicine: a study of patients, treatments, and practitioners . Ann Intern Med , 101 : 105 – 112 .
   PubMed Web of Science ®Google Scholar
• Vapiwala , N , Mick , R DeNittis , A . 2005 . Initiation of complementary and alternative medical therapies by cancer patients during radiation therapy . Proc Am Soc Ther Radiat Oncol , 63 ( 1 Suppl ) : S451
   Google Scholar
• Gupta , D , Lis , C G and Birdsall , T C . 2005 . The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care . Support Care Cancer , 13 : 912 – 919 .
   PubMed Web of Science ®Google Scholar
• 2007 . Available at http://online.lexi.com/crlonline Lexi-Comp Online [Internet]: Hudson (OH): Lexi-drugs [cited 2007 Jun 6]
   Google Scholar
• National Comprehensive Cancer Network [Internet]: Jenkintown (PA) . 2007 . NCCN Clinical Practice Guidelines in Oncology Available at http://www.nccn.org/[cited 2007 Jun 12]
   Google Scholar
• Jaffe , B M . 1974 . Prostaglandins and cancer: an update . Prostaglandins , 6 : 453 – 461 .
   PubMed Web of Science ®Google Scholar
• Husby , G , Strickland , R G , Rigler , G L , Peake , G T and Williams , R C Jr. 1977 . Direct immunochemical detection of prostaglandin-E and cyclic nucleotides in human malignant tumors . Cancer , 40 : 1629 – 1642 .
   PubMed Web of Science ®Google Scholar
• Lupulescu , A . 1978 . Enhancement of carcinogenesis by prostaglandins . Nature , 272 : 634 – 636 .
   PubMed Web of Science ®Google Scholar
• Sheng , H , Shao , J , Morrow , J D , Beauchamp , R D and DuBois , R N . 1998 . Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells . Cancer Res , 58 : 362 – 366 .
   PubMed Web of Science ®Google Scholar
• Thun , M J . 1996 . NSAID use and decreased risk of gastrointestinal cancers . Gastroenterol Clin North Am , 25 : 333 – 348 .
   PubMed Web of Science ®Google Scholar
• Moon , R C , Kelloff , G J , Detrisac , C J , Steele , V E Thomas , C F . 1993 . Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxi Nutritional supplements . Carcinogenesis , 14 : 1487 – 1489 .
   PubMed Web of Science ®Google Scholar
• Giardiello , F M , Hamilton , S R , Krush , A J , Piantadosi , S Hylind , L M . 1993 . Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis . N Engl J Med , 328 : 1313 – 1316 .
   PubMed Web of Science ®Google Scholar
• Steele , V E , Hawk , E T , Viner , J L and Lubet , R A . 2002 . Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer . Mutat Res , 523-524 : 137 – 144 .
   Web of Science ®Google Scholar
• Tsujii , M , Kawano , S , Tsuji , S , Sawaoka , H Hori , M . 1998 . Cyclooxygenase regulates angiogenesis induced by colon cancer cells . Cell , 93 : 705 – 716 .
   PubMed Web of Science ®Google Scholar
• Shiff , S J , Koutsos , M I , Qiao , L and Rigas , B . 1996 . Non-steroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis . Exp Cell Res , 222 : 179 – 188 .
   PubMed Web of Science ®Google Scholar
• Marnett , L J . 1992 . Aspirin and the potential role of prostaglandins in colon cancer . Cancer Res , 52 : 5575 – 5589 .
   PubMed Web of Science ®Google Scholar
• 2009 . Physician's Desk Reference , Montvale, NJ : Thomson Reuters, Inc. .
   Google Scholar
• Xu , X J , Shi , S W Tang , Y M . 2007 . Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia . Zhongguo Dang Dai Er Ke Za Zhi , 9 : 28 – 33 .
   PubMedGoogle Scholar
• Jagdeo , J , Campbell , R , Long , T , Muglia , J Telang , G . 2007 . Sweet's syndrome-like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia . J Am Acad Dermatol , 56 : 690 – 693 .
   PubMed Web of Science ®Google Scholar
• Delia , P , Sansotta , G , Donato , V , Frosina , P Messina , G . 2007 . Use of probiotics for prevention of radiation-induced diarrhea . World J Gastroenterol , 13 : 912 – 915 .
   PubMed Web of Science ®Google Scholar
• Le Leu , R K , Brown , I L , Hu , Y , Bird , A R Jackson , M . 2005 . A symbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon . J Nutr , 135 : 996 – 1001 .
   PubMed Web of Science ®Google Scholar
• Natural Standard . 2007 . The Authority on Integrative Medicine [Internet] , Nutritional supplements bridge . Available at http://www.naturalstandard.com/[cited 2007 Jun 12]
   Google Scholar
• Kiefer , I , Prock , P , Lawrence , C , Wise , J Bieger , W . 2004 . Supplementation with mixed fruit and vegetable juice concentrates increased serum antioxidants and folate in healthy adults . J Am Coll Nutr , 23 : 205 – 11 .
   PubMed Web of Science ®Google Scholar
• Peters , U , Foster , C B , Chatterjee , N , Schatzkin , A Reding , D . 2007 . Serum selenium and risk of prostate cancer—a nested case-control study . Am J Clin Nutr , 85 : 209 – 217 .
   PubMed Web of Science ®Google Scholar
• Sakoda , L C , Graubard , B I , Evans , A A , London , W T Lin , W Y . 2005 . Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City . Int J Cancer , 115 : 618 – 624 .
   PubMed Web of Science ®Google Scholar
• Hercberg , S , Galan , P , Preziosi , P , Bertrais , S Mennen , L . 2004 . The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals . Arch Intern Med , 164 : 2335 – 2342 .
   PubMed Web of Science ®Google Scholar
• Lambert , J D and Yang , C S . 2003 . Proceedings of the third international Scientific Symposium on Tea and Human Health: role of flavonoids in the diet: mechanisms of cancer prevention by tea constituents . J Nutr , 133 : 3262S – 3267S .
   PubMed Web of Science ®Google Scholar
• Mukhtar , H and Ahmad , N . 2000 . Tea polyphenols: prevention of cancer and optimizing health . Am J Clin Nutr , 71 ( Suppl ) : 1698S – 1702S .
   PubMed Web of Science ®Google Scholar
• Fujiki , H , Suganuma , M , Okabe , S , Sueoka , E Suga , K . 1999 . Mechanistic findings of green tea as cancer preventive for humans . Proc Soc Exp Biol Med , 220 : 225 – 228 .
   PubMed Web of Science ®Google Scholar
• Masuda , M , Suzui , M , Lim , J TE and Weinstein , I B . 2003 . Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells . Clin Cancer Res , 9 : 3486 – 3491 .
   PubMed Web of Science ®Google Scholar
• Gupta , S , Hastak , K , Ahmad , N , Lewin , J S Mukhtar , H . 2001 . Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols . Proc Natl Acad Sci USA , 98 : 10350 – 10355 .
   PubMed Web of Science ®Google Scholar
• Jung , Y D , Kim , M S , Shin , B A , Chay , K O Ahn , B W . 2001 . EGCG, a major component of green tea, inhibits tumor growth by inhibiting VEGF induction in human colon carcinoma cells . Br J Cancer , 84 : 844 – 850 .
   PubMed Web of Science ®Google Scholar
• Sadzuka , Y , Sugiyama , T and Sonobe , T . 2000 . Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance . Toxicol Lett , 114 : 155 – 162 .
   PubMed Web of Science ®Google Scholar
• Stewart , J R , Artime , M C and O'Brian , C A . 2003 . Resveratrol: a candidate nutritional substance for prostate cancer prevention . J Nutr , 133 : 2440S – 2443S .
   PubMed Web of Science ®Google Scholar
• Walle , T , Hsieh , F and DeLegge , M . 2004 . High absorption but very low bioavailability of oral resveratrol in humans . Drug Metab Dispos , 32 : 1377 – 1381 .
   PubMed Web of Science ®Google Scholar
• Stewart , J R , Ward , N E , Ioannides , C G and O'Brian , C A . 1999 . Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism . Biochemistry , 38 : 13244 – 13251 .
   PubMed Web of Science ®Google Scholar
• Bhat , K P , Lantvit , D , Christov , K , Mehta , R G Moon , R C . 2001 . Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models . Cancer Res , 20 : 7456 – 7463 .
   Google Scholar
• Mitchell , S H , Zhu , W and Young , C Y . 1999 . Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells . Cancer Res , : 5892 – 5895 .
   PubMed Web of Science ®Google Scholar
• Stojanovic , S , Sprinz , H and Brede , O . 2001 . Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation . Arch Biochem Biophys , 391 : 79 – 89 .
   PubMed Web of Science ®Google Scholar
• Ciolino , H P and Yeh , G C . 1999 . Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol . Mol Pharmacol , 56 : 760 – 767 .
   PubMed Web of Science ®Google Scholar
• Jang , M , Cai , L , Udeani , G O , Slowing , K V Thomas , C F . 1997 . Cancer chemopreventive activity of resveratrol, a natural product derived from grapes . Science , 275 : 218 – 220 .
   PubMed Web of Science ®Google Scholar
• Tyagi , A , Singh , R P , Agarwal , C , Siriwardana , S Sclafani , R A . 2005 . Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells . Carcinogenesis , 26 : 1978 – 1987 .
   PubMed Web of Science ®Google Scholar
• Laio , H-F , Kuo , C-D and Yang , Y-C . 2005 . Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation . J Radiat Res , 46 : 387 – 393 .
   PubMed Web of Science ®Google Scholar
• Subbaramaiah , K , Chung , W J , Michaluart , P , Telang , N Tanabe , T . 1998 . Resveratrol inhibits COX-2 transcription and activity in phorbol ester-treated human mammary epithelial cells . J Biol Chem , 273 : 21875 – 21882 .
   PubMed Web of Science ®Google Scholar
• Gusman , J , Malonne , H and Atassi , G . 2001 . A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol . Carcinogenesis , 22 : 1111 – 1117 .
   PubMed Web of Science ®Google Scholar
• Mousa , A S and Mousa , S A . 2005 . Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53 . Nutr Cancer , 53 : 104 – 110 .
   PubMed Web of Science ®Google Scholar
• Malik , A , Afaq , F , Sarfaraz , S , Adhami , V M Syed , D N . 2005 . Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer . Proc Natl Acad Sci USA , 102 : 14813 – 14818 .
   PubMed Web of Science ®Google Scholar
• DeSmet , P A . 2004 . Health risks of herbal remedies: an update . Clin Pharmacol Ther , 76 : 1 – 17 .
   PubMed Web of Science ®Google Scholar
• Infante , P F and White , M C . 1983 . Benzene: epidemiologic observations of leukemia by cell type and adverse health effects associated with low-level exposure . Environ Health Perspect , 52 : 75 – 82 .
   PubMed Web of Science ®Google Scholar
• Bandera , E V , Kushi , L H , Moore , D F , Gifkins , D M and McCollough , M L . 2007 . Review: fruits and vegetable and endometrial cancer risk: a systematic literature review and meta-analysis . Nutr Cancer , 58 : 6 – 21 .
   PubMed Web of Science ®Google Scholar